CORONARY INTERVENTIONS

Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study

EuroIntervention 2017;12:2009-2017 published online January 2017. DOI: 10.4244/EIJ-D-16-00884

Per Grimfjärd1,2*, MD; David Erlinge3, MD, PhD; Sasha Koul3, MD, PhD; Bo Lagerqvist1,4, MD, PhD; Bodil Svennblad4, MSc, PhD; Christoph Varenhorst1,4, MD, PhD; Stefan K. James1,4, MD, PhD

1. Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; 2. Department of Cardiology, Västerås Hospital, Västerås, Sweden; 3. Department of Cardiology, Skåne University Hospital, Lund University, Lund, Sweden; 4. Uppsala Clinica

Aims: The aim of the study was to compare outcomes in unfractionated heparin (UFH) and bivalirudin-treated patients undergoing primary percutaneous coronary intervention (PPCI).

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

adjunctive pharmacotherapyclinical researchstemistent thrombosis

Coronary interventionsSTEMIAdjunctive pharmacotherapy

Share on Facebook Share on Twitter Share on Linkedin